Related Experiment Videos
Selective inactivation of MAO-B by benzyl-dimethyl-silyl-methanamines in vitro
C Danzin1, J N Collard, P Marchal
1Merrell Dow Research Institute, Strasbourg, France.
Abstract:
The alpha-silyl amines benzyl-dimethyl-silyl-methanamine and the p-fluoro and p-chloro derivatives are potent time-dependent inhibitors of rat brain MAO-B. The inhibition exhibits saturation kinetics, takes place in the enzyme active-site and is irreversible. The most potent inhibitor in the series is 4-fluorobenzyl-dimethyl-silyl-methanamine (KI = 11 microM, tau 1/2 = 2.3 min). Its selectivity for the B-form relative to the A-form of rat brain MAO is higher than 10(4). Benzyl-dimethyl-silyl-methanamines may represent a new family of anti-Parkinsonian agents.
Insights
New alpha-silyl amines are potent, irreversible inhibitors of monoamine oxidase B (MAO-B). The 4-fluorobenzyl derivative shows high selectivity and potency, suggesting potential as novel anti-Parkinsonian agents.
Area of Science:
- Biochemistry
- Enzyme Inhibition
- Neuroscience
Background:
- Monoamine oxidase B (MAO-B) is a key enzyme in dopamine metabolism.
- MAO-B inhibitors are crucial for managing Parkinson's disease.
- Developing selective and potent MAO-B inhibitors is an ongoing research area.
Purpose of the Study:
- To investigate the inhibitory potential of alpha-silyl amines on rat brain MAO-B.
- To characterize the kinetics and mechanism of inhibition.
- To evaluate the selectivity of these compounds for MAO-B over MAO-A.
Main Methods:
- Synthesis of benzyl-dimethyl-silyl-methanamine derivatives.
- Enzyme inhibition assays using rat brain monoamine oxidase.
- Kinetic analysis to determine inhibition constants (KI) and half-life (tau 1/2).
- Selectivity studies comparing MAO-A and MAO-B inhibition.
Main Results:
- Alpha-silyl amines, including benzyl-dimethyl-silyl-methanamine and its p-fluoro and p-chloro derivatives, are potent time-dependent inhibitors of rat brain MAO-B.
- Inhibition follows saturation kinetics and is irreversible, occurring within the enzyme's active site.
- 4-fluorobenzyl-dimethyl-silyl-methanamine demonstrated the highest potency (KI = 11 microM, tau 1/2 = 2.3 min).
- This compound exhibited high selectivity for MAO-B over MAO-A (selectivity > 10^4).
Conclusions:
- Benzyl-dimethyl-silyl-methanamines represent a novel class of irreversible MAO-B inhibitors.
- The high potency and selectivity of 4-fluorobenzyl-dimethyl-silyl-methanamine warrant further investigation.
- These compounds hold promise as potential therapeutic agents for Parkinson's disease.